Menu Menu
 

INVEST Publications Subscribe to RSS Feed

Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.

Posted: Feb 27th, 2015

G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.

Posted: Feb 27th, 2015

Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort.

Posted: Feb 27th, 2015

Loci influencing blood pressure identified using a cardiovascular gene-centric array.

Posted: Feb 27th, 2015

Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.

Posted: Feb 27th, 2015

Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.

Posted: Feb 27th, 2015

Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.

Posted: Feb 27th, 2015

Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.

Posted: Feb 27th, 2015

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Posted: Feb 27th, 2015

Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.

Posted: Feb 27th, 2015